Eurobio Scientific SA (ALERS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.030x

Based on the latest financial reports, Eurobio Scientific SA (ALERS) has a cash flow conversion efficiency ratio of 0.030x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€5.36 Million ≈ $6.26 Million USD) by net assets (€180.85 Million ≈ $211.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALERS stock market capitalisation for the company's overall valuation and market capitalisation.

Eurobio Scientific SA - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Eurobio Scientific SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eurobio Scientific SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurobio Scientific SA ranked by their cash flow conversion efficiency. Explore Eurobio Scientific SA cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tatry Mountain Resorts a.s. PR:TMR	N/A
Aurora Cannabis Inc NASDAQ:ACB	-0.008x
Canaan Inc NASDAQ:CAN	-0.742x
Iones Co. Ltd KQ:114810	-0.011x
Blue Bird Tbk PT JK:BIRD	0.040x
BT Group Plc LSE:BT-A	0.297x
W-SCOPE CHUNGJU PLANT LTD (PROPOSE KQ:393890	-0.002x
Decora SA WAR:DCR	0.032x

Annual Cash Flow Conversion Efficiency for Eurobio Scientific SA (2007–2024)

The table below shows the annual cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024. View today's stock price for Eurobio Scientific SA for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€178.85 Million ≈ $209.10 Million	€16.70 Million ≈ $19.53 Million	0.093x	-38.88%
2023-12-31	€175.17 Million ≈ $204.80 Million	€26.77 Million ≈ $31.29 Million	0.153x	-38.74%
2022-12-31	€172.67 Million ≈ $201.87 Million	€43.07 Million ≈ $50.36 Million	0.249x	-39.36%
2021-12-31	€160.22 Million ≈ $187.32 Million	€65.92 Million ≈ $77.06 Million	0.411x	-19.23%
2020-12-31	€107.84 Million ≈ $126.08 Million	€54.93 Million ≈ $64.22 Million	0.509x	+273.22%
2019-12-31	€36.56 Million ≈ $42.75 Million	€4.99 Million ≈ $5.83 Million	0.136x	+872.96%
2018-12-31	€29.62 Million ≈ $34.63 Million	€-523.00K ≈ $-611.44K	-0.018x	-122.61%
2017-12-31	€31.69 Million ≈ $37.05 Million	€2.48 Million ≈ $2.89 Million	0.078x	+128.78%
2016-12-31	€12.23 Million ≈ $14.29 Million	€-3.32 Million ≈ $-3.88 Million	-0.271x	-158.84%
2015-12-31	€23.31 Million ≈ $27.25 Million	€-2.44 Million ≈ $-2.86 Million	-0.105x	+13.43%
2014-12-31	€27.95 Million ≈ $32.67 Million	€-3.38 Million ≈ $-3.96 Million	-0.121x	+49.18%
2013-12-31	€20.56 Million ≈ $24.04 Million	€-4.90 Million ≈ $-5.73 Million	-0.238x	-31.31%
2012-12-31	€24.50 Million ≈ $28.64 Million	€-4.45 Million ≈ $-5.20 Million	-0.182x	+59.12%
2011-12-31	€13.57 Million ≈ $15.86 Million	€-6.02 Million ≈ $-7.04 Million	-0.444x	-46.82%
2010-12-31	€19.19 Million ≈ $22.44 Million	€-5.80 Million ≈ $-6.78 Million	-0.302x	-14.79%
2009-12-31	€25.46 Million ≈ $29.76 Million	€-6.71 Million ≈ $-7.84 Million	-0.263x	+73.33%
2008-12-31	€9.74 Million ≈ $11.39 Million	€-9.62 Million ≈ $-11.24 Million	-0.988x	-261.60%
2007-12-31	€18.07 Million ≈ $21.12 Million	€-4.93 Million ≈ $-5.77 Million	-0.273x	--

About Eurobio Scientific SA

PA:ALERS France Medical Devices

Market Cap

$296.63 Million

€253.72 Million EUR

Market Cap Rank

#16009 Global

#231 in France

Share Price

€25.20

Change (1 day)

+0.40%

52-Week Range

€19.20 - €25.55

All Time High

€28.88